The research, which is reported in the June 25 edition of Science, was led by Stephen Buchwald, the Camille Dreyfus Professor of Chemistry at the Massachusetts Institute of Technology.
Watson worked in Buchwald's lab at MIT as a postdoctoral research associate prior to joining the UD Department of Chemistry and Biochemistry as an assistant professor this past September.
About 25 percent of pharmaceuticals contain fluorine, according to Watson, but it's difficult to incorporate the element into drug molecules. Numerous researchers have been working to develop general methods to introduce fluorine atoms into organic molecules under mild reaction conditions.
“The introduction of fluorine atoms into a pharmaceutical compound can have pronounced effects,” Watson notes. “They can modulate the uptake of the drug and stabilize it against metabolism by the body, keeping it in a person's system longer and making it more effective.”
The chemical method discovered by the research team uses a soluble palladium (a precious metal) catalyst to replace a chlorine atom in an aromatic molecule with a trifluoromethyl (CF3) group, which contains one carbon and three fluorine atoms. The process is highly general and occurs under mild conditions, and may become even more economical in the future as less expensive reagents are identified, Watson says.
Watson's role in the research effort was in early stage development. He dissected the complex chemical process into manageable pieces, isolating the first compounds critical to the reaction and demonstrating their effectiveness.
This is the second article in this research field that the team has published in Science during the past year. The work on which the first article is based will result in Watson's first patent, co-authored with colleagues at MIT.
Today, in his laboratory at UD, Watson works on developing homogeneous transition metal-based catalysts for use in organic chemistry. He hopes the processes that he is discovering will find use in pharmaceutical, agrichemical, and alternative energy research.
His aim is to help build the chemist's toolkit, providing tools -- in the form of chemical reactions -- that other chemists can use to make new molecules.
“In my lab we do basic science that has the potential for real-world applications,” Watson says. “We're working with the nuts and bolts, getting to develop stuff that other scientists can use. It's exhilarating to do research that will impact the way chemists build molecules.
“Making molecules and new catalysts is exciting,” he adds. “To be able to sketch out a new compound and then make a new substance is a unique experience. It's pretty thrilling to be able to create new substances that other people have never seen before.”
Watson has a growing laboratory group, with three graduate students, an undergraduate student, and a laboratory assistant.
“They are an incredible group of hard-working and highly talented students, and their science will have an impact,” he says.
He knows that the experience in his lab has the potential to transform their lives just as his lab experiences did.
As an undergraduate, Watson explains, his interests were torn -- would he pursue physics, chemistry, or chemical engineering? Then as a sophomore in college he got involved in laboratory research in organic chemistry. The opportunity to work on something someone hadn't worked on before hooked him.
“I really like having undergraduate and early graduate students in the lab with me now,” Watson notes. “Being able to work with young scientists who are just getting started is very rewarding. I hope that I will be able to show them how exciting and important this field is. Being able to return that favor to others is a great privilege in this job.”
Tracey Bryant | EurekAlert!
North and South Cooperation to Combat Tuberculosis
22.03.2018 | Universität Zürich
Researchers Discover New Anti-Cancer Protein
22.03.2018 | Universität Basel
An international team of researchers has discovered a new anti-cancer protein. The protein, called LHPP, prevents the uncontrolled proliferation of cancer cells in the liver. The researchers led by Prof. Michael N. Hall from the Biozentrum, University of Basel, report in “Nature” that LHPP can also serve as a biomarker for the diagnosis and prognosis of liver cancer.
The incidence of liver cancer, also known as hepatocellular carcinoma, is steadily increasing. In the last twenty years, the number of cases has almost doubled...
In just a few weeks from now, the Chinese space station Tiangong-1 will re-enter the Earth's atmosphere where it will to a large extent burn up. It is possible that some debris will reach the Earth's surface. Tiangong-1 is orbiting the Earth uncontrolled at a speed of approx. 29,000 km/h.Currently the prognosis relating to the time of impact currently lies within a window of several days. The scientists at Fraunhofer FHR have already been monitoring Tiangong-1 for a number of weeks with their TIRA system, one of the most powerful space observation radars in the world, with a view to supporting the German Space Situational Awareness Center and the ESA with their re-entry forecasts.
Following the loss of radio contact with Tiangong-1 in 2016 and due to the low orbital height, it is now inevitable that the Chinese space station will...
Fraunhofer Institute for Organic Electronics, Electron Beam and Plasma Technology FEP, provider of research and development services for OLED lighting solutions, announces the founding of the “OLED Licht Forum” and presents latest OLED design and lighting solutions during light+building, from March 18th – 23rd, 2018 in Frankfurt a.M./Germany, at booth no. F91 in Hall 4.0.
They are united in their passion for OLED (organic light emitting diodes) lighting with all of its unique facets and application possibilities. Thus experts in...
A new scenario seeking to explain how Mars' putative oceans came and went over the last 4 billion years implies that the oceans formed several hundred million...
For the first time, an interdisciplinary team from the University of Basel has succeeded in integrating artificial organelles into the cells of live zebrafish embryos. This innovative approach using artificial organelles as cellular implants offers new potential in treating a range of diseases, as the authors report in an article published in Nature Communications.
In the cells of higher organisms, organelles such as the nucleus or mitochondria perform a range of complex functions necessary for life. In the networks of...
19.03.2018 | Event News
16.03.2018 | Event News
13.03.2018 | Event News
22.03.2018 | Trade Fair News
22.03.2018 | Earth Sciences
22.03.2018 | Earth Sciences